Peripheral Nerve Field Stimulation Control via Physiological Feedback

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current medical devices for pain management, such as those using neurostimulation and therapeutic agents, often rely on fixed stimulation protocols that do not adapt to individual patient responses, leading to inefficiencies and potential discomfort due to lack of real-time feedback on physiological effects.

Innovation Solution

The development of a system that uses implanted electrodes to deliver peripheral nerve field stimulation (PNFS) based on detected physiological responses, allowing for closed-loop control of therapy delivery by monitoring parameters like heart rate, muscle activity, and skin conductance to adjust stimulation in real-time.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Ease of operation

If fixed stimulation protocols are used for pain management, then device complexity is reduced and ease of operation is improved, but adaptability to individual patient responses deteriorates and therapy effectiveness is reduced

Engineering Contradiction:
Improveease of operationVSAvoidadaptability
Core Design Contradiction:
Ease of operationVSAdaptability or versatility

Solution Approach 1:

The patent implements closed-loop control by detecting physiological responses (such as muscle activity via EMG, skin conductance, or heart rate) and using this feedback to automatically adjust stimulation parameters. The IMD continuously monitors patient responses and modifies stimulation intensity, frequency, or pulse width in real-time to optimize pain relief while adapting to individual variations in patient response.

Inventive Principle:
Principle #23Feedback

2Adaptability or versatility

If real-time physiological monitoring is implemented for closed-loop control, then adaptability and therapy effectiveness are improved, but device complexity and measurement difficulty increase

Engineering Contradiction:
ImproveadaptabilityVSAvoiddevice complexity
Core Design Contradiction:
Adaptability or versatilityVSDevice complexity

Solution Approach 1:

The patent employs electrodes that serve dual functions: delivering electrical stimulation therapy and detecting physiological responses. The same electrodes used for PNS can detect local field potentials, muscle activity, or other physiological signals, eliminating the need for separate sensing components and reducing overall device complexity while enabling closed-loop control.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Solution Approach 2:

The system uses the patient's own physiological signals to automatically control the stimulation parameters without requiring external intervention or complex external monitoring equipment. The IMD self-regulates by detecting its own effects on the patient's physiology and adjusting accordingly.

Inventive Principle:
Principle #25Self-service

3Reliability

If stimulation intensity is increased to improve pain relief, then therapy effectiveness is improved, but harmful effects such as muscle contractions and discomfort increase

Engineering Contradiction:
Improvetherapeutic effectivenessVSAvoidharmful effects
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent uses real-time detection of physiological responses (such as muscle contractions via EMG or skin conductance changes) as feedback signals to automatically adjust stimulation intensity. When harmful effects are detected, the system reduces stimulation parameters to prevent discomfort while maintaining effective pain relief through optimized parameter selection.

Inventive Principle:
Principle #23Feedback

Solution Approach 2:

The patent dynamically adjusts stimulation parameters based on real-time patient response rather than using fixed intensity levels. The system can vary pulse width, frequency, and amplitude in real-time to maximize therapeutic effect while minimizing harmful side effects, adapting the stimulation profile to the patient's instantaneous physiological state.

Inventive Principle:
Principle #15Dynamics

Data Source

PatentUS20230381520A1Peripheral nerve field stimulation control
Publication Date: 2023.11.30 MEDTRONIC INC
  • US20230381520A1 patent drawing
  • US20230381520A1 patent drawing
  • US20230381520A1 patent drawing

AI summary

Peripheral nerve field stimulation (PNFS) may be controlled based on detected physiological effects of the PNFS, which may be an efferent response to the PNFS. In some examples, a closed-loop therapy system may include a sensing module that senses a physiological parameter of the patient, which may be indicative of the patient's response to the PNFS. Based on a signal generated by the sensing module, the PNFS may be activated, deactivated or modified. Example physiological parameters of the patient include heart rate, respiratory rate, electrodermal activity, muscle activity, blood flow rate, sweat gland activity, pilomotor reflex, or thermal activity of the patient's body. In some examples, a patient pain state may be detected based on a signal generated by the sensing module, and therapy may be controlled based on the detection of the pain state.